Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited - pharma in Meerut, Uttar Pradesh, India. FY 2026 financials and compliance.
CIN U24233UP1985PLC007205 Incorporated 28 May 1985 ROC Kanpur HQ Meerut, Uttar Pradesh, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2023
₹30.18 Cr
▲ 31.92% YoY
EBITDA · FY 2023
Locked
In full report
Net profit · FY 2023
Locked
In full report
Authorised capital
₹5.5 Cr
Registered with MCA
Paid-up capital
₹3.23 Cr
Issued & subscribed
Open charges
₹16.93 Cr
Secured borrowings
Company age
41 yrs
Est. 1985
Employees · EPFO
11
Latest available

About Daffodills Pharmaceuticals Limited

Data last updated: 01 January 2026

Daffodills Pharmaceuticals Limited is a public limited company based in Meerut, Uttar Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 28 May 1985, the company has been in operation for over 41 years.

Registered with ROC Kanpur under CIN U24233UP1985PLC007205.

Capital: an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹3.23 Cr. Formerly known as Daffodills Pharmaceutical Private Limited. It is led by directors including Pranav Chaudhary and Prateek Chaudhary.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, India – 250001.

As per the financials filed for FY 2023, the company reported a revenue of ₹30.18 Cr, a growth of 31.92% compared to the previous year.

The company has a workforce of approximately 11 employees as per the latest available data.

The company is associated with 1 brand - Daffodills. As per MCA filings, the company has open charges of ₹16.93 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daffodills.in.

Company Details of Daffodills Pharmaceuticals Limited
CIN U24233UP1985PLC007205
Registration Number 007205
Incorporation Date 28 May 1985
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, India – 250001
  • Industry
    Pharma, Drug Formulation & Development
Company report
Daffodills Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Daffodills Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Daffodills Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited has one previous CIN (Corporate Identification Number): L24233UP1985PLC007205. The current CIN is U24233UP1985PLC007205, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24233UP1985PLC007205 Current
L24233UP1985PLC007205 Previous

Associated Brands with Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited operates one associated brand: Daffodills. These brands represent Daffodills Pharmaceuticals Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures and exports high-quality pharmaceutical formulations for domestic and international markets. daffodills.in

Competitors & Alternatives of Daffodills Pharmaceuticals Limited

Brands and companies operating in the same space as Daffodills Pharmaceuticals Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 5 more.

Competitor Description Location Founded
Jubilant Life Sciences Jubilant Life Sciences Company offering a suite of R&D and manufacturing services for small molecules and generics Noida, India, India 1978
Akums Akums CDMO focusing on spectrum of dosage forms and therapeutic segments Delhi, India, India 2004
Nectar Lifesciences Nectar Lifesciences Cephalosporin APIs and generic formulations are manufactured. Chandigarh, India, India 1995
Windlas Windlas Biopharma regulatory affairs, quality control, and strategy services are provided. Gurugram, India, India 2001
Unither Unither Contract development and manufacturing organization for proprietary and generic drugs Paris, France, France 1993
Recipharm Recipharm Pharmaceutical development and manufacturing services are offered contractually. Jordbro, Sweden, Sweden 1995
CoreRx CoreRx CDMO with a focus on early phase drug product development Clearwater, United States, United States 2006
MedPharm MedPharm Topical and inhaled drug delivery formulations are developed and manufactured. Guildford, United Kingdom, United Kingdom 1998

Business Activity of Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited operates primarily in the manufacturing sector. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Detailed business activity records for Daffodills Pharmaceuticals Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited is audited by MEHRA AND COMPANY for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
MEHRA AND COMPANY Locked Locked Locked
Premium access

Complete auditor history for Daffodills Pharmaceuticals Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited is currently managed by 5 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Pranav Chaudhary Director 22 Feb 2012 14 Years 5 Months Current
Prateek Chaudhary Director 22 Feb 2012 14 Years 5 Months Current
Prabhat Kumar Rai Whole-Time Director 30 Jul 2019 7 Years 0 Months Current
Kunwar Krishanpal Singh Whole-Time Director 30 Jul 2019 7 Years 0 Months Current
Prashant Chaudhry Director 02 Aug 2018 8 Years 0 Months Current

Financials of Daffodills Pharmaceuticals Limited FY 2025 filings available

Daffodills Pharmaceuticals Limited reported revenue of ₹30.18 Cr (up 31.92% YoY) for FY 2023.

Revenue · FY 2023
₹30.18 Cr ▲ 31.92%
Premium access

Ten-year financial statements for Daffodills Pharmaceuticals Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Daffodills Pharmaceuticals Limited

Premium access

Shareholding and ownership data for Daffodills Pharmaceuticals Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Daffodills Pharmaceuticals Limited

Open charges
₹16.93 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Axis Bank Limited₹9.60 Cr
State Bank of India₹6.95 Cr
U. P. Financial Corporation₹0.38 Cr
Latest charge details
DateLenderAmountStatus
03 Oct 2025 State Bank of India ₹6.95 Cr Open
26 May 2025 Axis Bank Limited ₹4.6 Cr Open
20 Sep 2018 Axis Bank Limited ₹5 Cr Open
14 Oct 1995 U. P. Financial Corporation ₹38 Lakh Open

Total charge records: 4 View all charges

Employees and EPFO Compliance at Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited has a workforce of 11 employees as of Apr 01, 2024.

Employee count
11
Active EPFO establishments
1
Employee growth
10%
Premium access

Employee and EPFO history for Daffodills Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Daffodills Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Daffodills Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Daffodills Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Daffodills Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Daffodills Pharmaceuticals Limited

Premium access

MSME payment history for Daffodills Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Daffodills Pharmaceuticals Limited

Premium access

Corporate group structure for Daffodills Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Daffodills Pharmaceuticals Limited

Premium access

MCA filings and documents for Daffodills Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Daffodills Pharmaceuticals Limited

Charges
03 Oct 2025
A charge with State Bank Of India amounted to Rs. 6.95 Cr with Charge ID 101161572 was registered on 03 Oct 2025.
Activity
30 Sep 2025
Daffodills Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
26 May 2025
A charge with Axis Bank Limited amounted to Rs. 4.60 Cr with Charge ID 101120639 was registered on 26 May 2025.
Activity
31 Mar 2025
Daffodills Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Directors
30 Jul 2019
Prabhat Kumar Rai was appointed as a Whole-time director on 30 Jul 2019 & has been associated with this company since 7 years 22 days.
Directors
30 Jul 2019
Kunwar Krishanpal Singh was appointed as a Whole-time director on 30 Jul 2019 & has been associated with this company since 7 years 22 days.

Frequently Asked Questions about Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited is an active public limited company in the pharma sector based in Meerut, Uttar Pradesh, India. It was incorporated on 28 May 1985 (41+ years old) and is registered under CIN U24233UP1985PLC007205. The company has 11 employees.

Daffodills Pharmaceuticals Limited reported revenue of ₹30.18 Cr for FY 2023 (up 31.92% YoY).

The current directors of Daffodills Pharmaceuticals Limited are:

The primary industry of Daffodills Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Daffodills Pharmaceuticals Limited can be reached at the registered office: 7701 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, India – 250001, or through the website daffodills.in.

The authorised capital is ₹5.5 Cr, and the paid-up capital is ₹3.23 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available